Sign inGet started

Venrock Partners Management VI, LLC

Insider CIK 1495385 · CSLT 10% owner · AAVL 10% owner · TXG 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CSLT CASTLIGHT HEALTH, INC. D To issuer deriv2022-02-172022-02-1815,568,571— $00SEC↗
CSLT CASTLIGHT HEALTH, INC. D To issuer2022-02-172022-02-185,255,264— $00SEC↗
TXG 10x Genomics, Inc. J Other2020-12-102020-12-10268,692— $02,037,825SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2020-12-082020-12-103,000,000— $05,790,422SEC↗
TXG 10x Genomics, Inc. J Other2020-12-082020-12-10731,308— $02,306,517SEC↗
TXG 10x Genomics, Inc. C Conversion2020-12-082020-12-103,000,000— $03,037,825SEC↗
TXG 10x Genomics, Inc. J Other2020-09-182020-09-18338,019— $037,825SEC↗
TXG 10x Genomics, Inc. J Other2020-09-162020-09-18911,981— $0375,844SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2020-05-202020-05-221,013,569— $08,790,422SEC↗
TXG 10x Genomics, Inc. S Sale2020-05-202020-05-221,013,569$78.00 $79.06M1,287,825SEC↗
TXG 10x Genomics, Inc. C Conversion2020-05-202020-05-221,013,569— $02,301,394SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2020-05-012020-05-011,287,825— $09,803,991SEC↗
TXG 10x Genomics, Inc. C Conversion2020-05-012020-05-011,287,825— $01,287,825SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2019-09-162019-09-1611,091,816— $011,091,816SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2019-09-162019-09-163,272,171— $00SEC↗
TXG 10x Genomics, Inc. C Conversion deriv2019-09-162019-09-167,819,645— $00SEC↗
CSLT CASTLIGHT HEALTH, INC. A Award2017-04-032019-06-073,998,534— $05,255,264SEC↗
CSLT CASTLIGHT HEALTH, INC. A Award2017-04-032017-04-053,965,979— $05,222,709SEC↗
AAVL Avalanche Biotechnologies, C Conversion deriv2014-08-052014-08-071,965,471— $00SEC↗
AAVL Avalanche Biotechnologies, C Conversion2014-08-052014-08-071,965,471— $01,965,471SEC↗
AAVL Avalanche Biotechnologies, P Buy2014-08-052014-08-07400,000$17.00 $6.80M2,365,471SEC↗